文献速递糖尿病

妊娠期糖尿病新诊断标准及其对诊断数量与妊娠结局的影响

New diagnostic criteria for gestational diabetes mellitus and their impact on the number of diagnoses and pregnancy outcomes.
PubMed 文献 · Diabetologia · 2017-11-22

研究基于10,642名接受75 g OGTT的孕妇,比较WHO 1999与WHO 2013标准对妊娠期糖尿病诊断数量及妊娠结局的影响。应用WHO 2013标准使诊断数量增加45%(32% vs 22%)。仅按WHO 2013空腹血糖阈值诊断且未治疗的孕妇,与血糖正常孕妇相比,不良妊娠结局风险增加。作者支持在荷兰国家指南中采用更低的空腹血糖阈值。

要点

  • 应用WHO 2013标准使GDM诊断数量增加45%(32% vs 22%)。
  • 仅符合WHO 2013空腹血糖阈值且未治疗者,妊娠高血压、计划剖宫产、引产及新生儿5分钟Apgar评分<7和新生儿科入住率均高于血糖正常孕妇。
  • 作者支持在荷兰国家指南中采用更低的空腹血糖阈值。

核心结论

  • 应用WHO 2013标准将对GDM诊断数量产生重大影响。
  • 采用WHO 2013空腹血糖阈值可识别出与血糖正常孕妇相比不良结局风险增加的孕妇群体。
  • 作者因此支持在荷兰国家指南中采用更低的空腹血糖阈值用于GDM诊断。
  • 但采用WHO 2013标准中更高的2小时血糖阈值将排除那些GDM治疗似乎有效的孕妇。

研究设计与样本

  • 数据来自10,642名因GDM危险因素或提示GDM的体征而接受75 g OGTT的孕妇。
  • 按WHO 1999标准诊断GDM者接受治疗。
  • 妊娠结局数据来自4,431名孕妇的详细病历回顾,比较血糖正常(NGT)与以下四组:1)按WHO 1999标准诊断的GDM;2)按WHO 2013标准诊断的GDM;3)符合WHO 2013空腹血糖阈值但不符合WHO 1999标准;4)符合WHO 1999 2小时血浆葡萄糖阈值(2HG)但不符合WHO 2013标准。

主要发现

  • 应用WHO 2013标准使该GDM较高风险孕妇群体的诊断数量增加45%(32% vs 22%)。
  • 与NGT孕妇相比,仅按WHO 2013空腹血糖阈值诊断且未治疗的GDM孕妇,孕前肥胖比例更高(46.1% vs 28.1%,p < 0.001),孕前高血压比例更高(3.3% vs 1.2%,p < 0.001)。
  • 上述未治疗组妊娠高血压发生率更高(7.8% vs 4.9%,p = 0.003),计划剖宫产率更高(10.3% vs 6.5%,p = 0.001),引产率更高(34.8% vs 28.0%,p = 0.001)。
  • 上述未治疗组新生儿5分钟Apgar评分<7的比例更高(4.4% vs 2.6%,p = 0.015),入住新生儿科的比例更高(15.0% vs 11.1%,p = 0.004)。
  • 上述未治疗组与NGT组之间大于胎龄儿(LGA)数量无显著差异。

关键数值与推荐

  • WHO 1999标准:用于诊断并治疗GDM。
  • WHO 2013标准:应用后GDM诊断数量增加45%(32% vs 22%)。
  • WHO 2013空腹血糖阈值:仅符合此阈值且未治疗者,孕前肥胖46.1% vs NGT 28.1%(p < 0.001),孕前高血压3.3% vs 1.2%(p < 0.001)。
  • WHO 2013空腹血糖阈值组:妊娠高血压7.8% vs 4.9%(p = 0.003),计划剖宫产10.3% vs 6.5%(p = 0.001),引产34.8% vs 28.0%(p = 0.001)。
  • WHO 2013空腹血糖阈值组:新生儿5分钟Apgar评分<7为4.4% vs 2.6%(p = 0.015),入住新生儿科15.0% vs 11.1%(p = 0.004)。

临床怎么用

  • 作者支持在荷兰国家指南中采用更低的空腹血糖阈值用于GDM诊断。
  • 作者指出采用WHO 2013标准中更高的2HG阈值将排除那些GDM治疗似乎有效的孕妇。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Detection and management of gestational diabetes mellitus (GDM) are crucial to reduce the risk of pregnancy-related complications for both mother and child. In 2013, the WHO adopted new diagnostic criteria for GDM to improve pregnancy outcomes. However, the evidence supporting these criteria is limited. Consequently, these new criteria have not yet been endorsed in the Netherlands. The aim of this study was to determine the impact of these criteria on the number of GDM diagnoses and pregnancy outcomes. METHODS: Data were available from 10,642 women who underwent a 75 g OGTT because of risk factors or signs suggestive of GDM. Women were treated if diagnosed with GDM according to the WHO 1999 criteria. Data on pregnancy outcomes were obtained from extensive chart reviews from 4,431 women and were compared between women with normal glucose tolerance (NGT) and women classified into the following groups: (1) GDM according to WHO 1999 criteria; (2) GDM according to WHO 2013 criteria; (3) GDM according to WHO 2013 fasting glucose threshold, but not WHO 1999 criteria; and (4) GDM according to WHO 1999 2 h plasma glucose threshold (2HG), but not WHO 2013 criteria. RESULTS: Applying the new WHO 2013 criteria would have increased the number of diagnoses by 45% (32% vs 22%) in this population of women at higher risk for GDM. In comparison with women with NGT, women classified as having GDM based only on the WHO 2013 threshold for fasting glucose, who were not treated for GDM, were more likely to have been obese (46.1% vs 28.1%, p < 0.001) and hypertensive (3.3% vs 1.2%, p < 0.001) before pregnancy, and to have had higher rates of gestational hypertension (7.8% vs 4.9%, p = 0.003), planned Caesarean section (10.3% vs 6.5%, p = 0.001) and induction of labour (34.8% vs 28.0%, p = 0.001). In addition, their neonates were more likely to have had an Apgar score <7 at 5 min (4.4% vs 2.6%, p = 0.015) and to have been admitted to the Neonatology Department (15.0% vs 11.1%, p = 0.004). The number of large for gestational age (LGA) neonates was not significantly different between the two groups. Women potentially missed owing to the higher 2HG threshold set by WHO 2013 had similar pregnancy outcomes to women with NGT. These women were all treated for GDM with diet and 20.5% received additional insulin. CONCLUSIONS/INTERPRETATION: Applying the WHO 2013 criteria will have a major impact on the number of GDM diagnoses. Using the fasting glucose threshold set by WHO 2013 identifies a group of women with an increased risk of adverse outcomes compared with women with NGT. We therefore support the use of a lower fasting glucose threshold in the Dutch national guideline for GDM diagnosis. However, adopting the WHO 2013 criteria with a higher 2HG threshold would exclude women in whom treatment for GDM seems to be effective.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Koning SH, van Zanden JJ, Hoogenberg K, et al. New diagnostic criteria for gestational diabetes mellitus and their impact on the number of diagnoses and pregnancy outcomes. Diabetologia. 2017. PMID: 29167927. doi:10.1007/s00125-017-4506-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。